VTRU yields 22.05% · PFE yields 6.13%● Live data
📍 VTRU pulled ahead of the other in Year 1
Combined, VTRU + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VTRU + PFE for your $10,000?
Vitru Limited, together with its subsidiaries, operates as a distance learning education company in the postsecondary digital education market in Brazil. It operates through three segments: Digital Education Undergraduate Courses, Continuing Education Courses, and On-Campus Undergraduate Courses. The company offers digital education undergraduate courses in hybrid methodology, which consists of weekly in-person meetings with on-site tutors. Its courses primarily comprise pedagogy, business administration, accounting, physical education, engineering, vocational education, and health-related courses. The company also offers continuing education courses primarily in pedagogy, finance, and business, as well as in other subjects, such as law, engineering, IT, and health-related courses through hybrid model, online, and on-campus. In addition, it operates 8 campuses that provides traditional on campus undergraduate courses, including business administration, accounting, physical education, engineering, law, and health-related courses. Vitru Limited was founded in 2014 and is headquartered in Florianópolis, Brazil.
Full VTRU Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.